Connect With a Global Community of 100+ Peptide Experts
The peptide therapeutics landscape is gaining unprecedented momentum, fueled by multi-billion-dollar investments from leading biopharma companies and the building proprietary peptide platforms and pipelines.
However, to keep up the rapid pace of development, requires unique and innovative solutions. Now is the time to secure your position in this rapidly evolving market. The 3rd Peptide-Based Therapeutics Summit brings together 100+ industry leaders driving the discovery and development of next-generation peptide drugs. These decision-makers are actively seeking partnerships with top solution providers to stay ahead in critical areas.
What to Expect?
Meeting New Peptide Developers & Providers
Expand your client base within the peptide community by networking face-to-face with dedicated attendees actively seeking solutions to overcome their drug development challenges.
Centring Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrating Your Expertise
Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Interest Areas
Our attendees from biopharma are looking for service and solution providers with capabilities in the below areas but not limited to:
AI/ML Technologies
Including quantum computing & cloud-based technologies that enable the prediction of peptide drug structure, function and folding
Peptide Screening
Fast, efficacious and cost-effective high throughput screening and of compounds that combine experimental methods to test and optimize computational hits
Peptide Formulation
Designing orally bioavailable peptides or novel routes of administration maintaining optimized PKPD properties
Peptide Synthesis, Manufacturing & CDMOs
Enabling the pre-clinical to clinical scale up of manufacturing with green chemistry to accelerate novel peptide drugs from concept to clinic and beyond
Analytical Assays
Verify and confirm peptide product properties, cell permeable functionality to ensure product quality and purity
Audience Composition
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Molly Biggin
Partnerships Director